(Q36457308)

14 August 2017

1 reference

title

Myelin disorders: Causes and perspectives of Charcot-Marie-Tooth neuropathy (English)

1 reference

14 August 2017

3

Klaus-Armin Nave

1 reference

14 August 2017

1

Gerd Meyer zu Hörste

1 reference

14 August 2017

Thomas Prukop

2

1 reference

14 August 2017

Michael W Sereda

series ordinal

4

1 reference

14 August 2017

publication date

1 January 2006

1 reference

Journal of Molecular Neuroscience

14 August 2017

published in

1 reference

14 August 2017

volume

28

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

77-88

1 reference

The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat.

14 August 2017

cites work

1 reference

12 December 2020

Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22.

1 reference

12 December 2020

Origin of the de novo duplication in Charcot — Marie — Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis

1 reference

12 December 2020

Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A

1 reference

12 December 2020

Clinical features and molecular genetics of hereditary peripheral neuropathies

1 reference

12 December 2020

Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties

1 reference

12 December 2020

Characterization and measurement of dehydroepiandrosterone sulfate in rat brain

1 reference

12 December 2020

Competitive inhibition of the glycine-induced current by pregnenolone sulfate in cultured chick spinal cord neurons.

1 reference

12 December 2020

The clinical features of hereditary motor and sensory neuropathy types I and II

1 reference

12 December 2020

Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).

1 reference

12 December 2020

Progesterone synthesis and myelin formation by Schwann cells

1 reference

12 December 2020

Progesterone synthesis and myelin formation in peripheral nerves

1 reference

12 December 2020

Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer

1 reference

12 December 2020

Aggresomes: a cellular response to misfolded proteins

1 reference

12 December 2020

A transgenic rat model of Charcot-Marie-Tooth disease

1 reference

12 December 2020

Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A.

1 reference

12 December 2020

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

1 reference

12 December 2020

Neurosteroids: biochemistry and clinical significance

1 reference

12 December 2020

Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor

1 reference

12 December 2020

Genetic and clinical aspects of Charcot-Marie-Tooth's disease

1 reference

12 December 2020

Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene

1 reference

12 December 2020

Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes

1 reference

12 December 2020

Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells

1 reference

12 December 2020

Neuroactive steroids and peripheral myelin proteins

1 reference

12 December 2020

Steroid modulation of the strychnine-sensitive glycine receptor

1 reference

12 December 2020

Charcot-Marie-Tooth neuropathies: from clinical description to molecular genetics

1 reference

12 December 2020

Progesterone receptor and the mechanism of action of progesterone antagonists

1 reference

12 December 2020

Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells.

1 reference

12 December 2020

Studies on neurosteroids XVII. Analysis of stress-induced changes in neurosteroid levels in rat brains using liquid chromatography-electron capture atmospheric pressure chemical ionization-mass spectrometry

1 reference

12 December 2020

Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.

1 reference

12 December 2020

Demonstration of progesterone receptors in rat Schwann cells.

1 reference

12 December 2020

1 reference

12 December 2020

Mutant dynactin in motor neuron disease.

1 reference

12 December 2020

Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice

1 reference

12 December 2020

Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta

1 reference

12 December 2020

Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression

1 reference

12 December 2020

Gene regulation by steroid hormones

1 reference

12 December 2020

Ultrastructural PMP22 expression in inherited demyelinating neuropathies

1 reference

12 December 2020

The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A

1 reference

12 December 2020

Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone

1 reference

12 December 2020

Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage

1 reference

12 December 2020

Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A.

1 reference

12 December 2020

PMP22 accumulation in aggresomes: implications for CMT1A pathology

1 reference

12 December 2020

The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication

1 reference

12 December 2020

Administration of progesterone produces mild sedative-like effects in men and women

1 reference

12 December 2020

Antiprogestin pharmacodynamics, pharmacokinetics, and metabolism: implications for their long-term use.

1 reference

12 December 2020

Combinatorial control of gene expression by nuclear receptors and coregulators

1 reference

12 December 2020

Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development

1 reference

12 December 2020

Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats.

1 reference

12 December 2020

Schwann cell myelination in a chemically defined medium: demonstration of a requirement for additives that promote Schwann cell extracellular matrix formation

1 reference

12 December 2020

The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A

1 reference

12 December 2020

Neurosteroids: biosynthesis and function of these novel neuromodulators

1 reference

12 December 2020

Transcriptional regulation by steroid receptor coactivator phosphorylation

1 reference

12 December 2020

Motor unit number estimate of distal and proximal muscles in Charcot-Marie-Tooth disease

1 reference

12 December 2020

Role of the extracellular matrix in myelination of peripheral nerve

1 reference

12 December 2020

Current Therapy for Charcot-Marie-Tooth Disease.

1 reference

12 December 2020

Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin

1 reference

12 December 2020

The two faces of a steroid antagonist: when an antagonist isn't

1 reference

12 December 2020

Molecular mechanisms of action of steroid/thyroid receptor superfamily members

1 reference

12 December 2020

Onion bulb cells in mice deficient for myelin genes share molecular properties with immature, differentiated non-myelinating, and denervated Schwann cells

1 reference

12 December 2020

Erythropoietin is neuroprotective in models of HIV sensory neuropathy

1 reference

12 December 2020

Disease mechanisms in inherited neuropathies

1 reference

12 December 2020

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease

1 reference

12 December 2020

Synthesis of progesterone in Schwann cells: regulation by sensory neurons.

1 reference

12 December 2020

Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor

1 reference

12 December 2020

Antioxidants are necessary for myelination of dorsal root ganglion neurons, in vitro

1 reference

12 December 2020

Effects of PMP22 duplication and deletions on the axonal cytoskeleton

1 reference

12 December 2020

Hereditary recurrent focal neuropathies: clinical and molecular features

1 reference

12 December 2020

Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist

1 reference

12 December 2020

Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation

1 reference

12 December 2020

DNA duplication associated with Charcot-Marie-Tooth disease type 1A

1 reference

12 December 2020

Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation

1 reference

12 December 2020

New steroids with antiprogestational and antiglucocorticoid activities

1 reference

12 December 2020

Pregnenolone sulfate potentiates the effects of NMDA on hippocampal alanine and dopamine

1 reference

12 December 2020

Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions

1 reference

12 December 2020

Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action.

1 reference

12 December 2020

Neurosteroids: beginning of the story

1 reference

12 December 2020

Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage

1 reference

12 December 2020

Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases.

1 reference

12 December 2020

Genetic epidemiology of hereditary motor sensory neuropathies (type I)

1 reference

12 December 2020

Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy

1 reference

12 December 2020

Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene

1 reference

12 December 2020

Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A

1 reference

12 December 2020

Charcot-Marie-Tooth disease: an update

1 reference

12 December 2020

Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication

1 reference

12 December 2020

Steroids, neuroactive steroids and neurosteroids in psychopathology

1 reference

12 December 2020

Neurosteroid modulation of GABAA receptors

1 reference

12 December 2020

Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a)

1 reference

12 December 2020

Identifiers

DOI

10.1385/JMN:28:1:77

1 reference

Dimensions Publication ID

14 August 2017

1006040780

0 references

1 reference